Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lamotrigine for Ketamine Dependence
NCT02556060Phase 3Completed
- Sponsor
- Taipei City Hospital
- Start
- Sep 2015
- Primary completion
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Lamofree ER in ketamine use disorder (KUD), sponsored by Taipei City Hospital. Started Sep 2015; status: completed.
02
Drugs
Lamofree ER
03
Conditions
ketamine use disorder (KUD)
Beyond the preview
Go deeper on NCT02556060.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02556060.